Hewes L. Becker's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Jun 8, 2022
- Accession no.
- 0001415889-22-006307
- Filed
- Jun 8, 2022
- Trade date
- Jun 6-7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $262.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hewes L. BeckerCIK 0001840110 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Common Stock | SSaleDisposed | −1,220 | $59.76 | −$72,907.2 | 30,451 | Direct | |
| Jun 7, 2022 | Common Stock | SSaleDisposed | −3,155 | $60.00 | −$189,300 | 27,296 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.